Clinical Trial Update: Ocular Biodistribution Study for Topically Applied ESBA105 [Phase 1, Phase 2]

View source ↗

Summary

This update notes the completion of an ocular biodistribution study of topically applied ESBA105 in a Phase 1/Phase 2 trial for cataract.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• ESBA105

Snippet

Sponsor: ESBATech AG | Conditions: Cataract | Phase 1, Phase 2 | Status: COMPLETED